Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy

Bone Marrow Transplantation

Volumn 21, Issue 10, 1998, Pages 1015-1021

  Messina, C ^a,l   Cesaro, S ^a   Rondelli, R ^b   Rossetti, F ^a   Locatelli, F ^c   Pession, A ^b   Miniero, R ^d   Dini, G ^e   Uderzo, C ^f   Dallorso, S ^e   Meloni, G ^g   Vignetti, M ^g   Andolina, M ^h   Porta, F ⁱ   Amici, A ^j   Favre, C ^k   Basso, G ^d   Sotti, G ^l   Varotto, S ^a   Destro, R ^a   Gazzola, M V ^a   Pillon, M ^a   Petris, M G ^a   Rabusin, M ^h   Scarzello, G ^l   Zanesco, L ^a   more..

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e G GASLINI INSTITUTE   (Italy)

^f SAN GERARDO HOSPITAL   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h UNIVERSITY OF TRIESTE   (Italy)

ⁱ UNIVERSITY OF BRESCIA   (Italy)

^j UNIVERSITY OF PERUGIA   (Italy)

^k UNIVERSITY OF PISA   (Italy)

^l UNIVERSITY HOSPITAL OF PADOVA   (Italy)

more..

Author keywords

ABMT; BM relapse; Childhood ALL; Isolated extramedullary relapse

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CHILD; CHILDHOOD LEUKEMIA; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RELAPSE; REMISSION; WHOLE BODY RADIATION;

EID: 0031799438     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701204     Document Type: Article

References (54)

1. Riehm H, Feickert HJ, Lampert F. Acute lymphoblastic leukemia. In: Voute PA, Barrett A, Bloom HG (eds). Cancer in Children: Clinical Management. Springer-Verlag: New York, 1986, pp 101-120.
2. Rivera GK, Pui CH, Hancock MI et al. Up-date of St Jude Study XI for Childhood Acute Lymphoblastic Leukemia. Leukemia 1992; 6 (Suppl. 2): 153-156.
3. Gaynon PS, Bleyer WA, Albo VC et al. Intensive therapy for children with acute lymphoblastic leukemia and unfavourable presenting features. Lancet 1988; 2: 921-924.
4. Feig SA, Harris RE, Sather HN. Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the Children's Cancer Group (CCG-1884). Med Pediatr Oncol 1997; 29: 534-540.
5. Henze G, Fenger R, Hartmann R et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-Rez BFM85). A relapse study of the BFM Group. Blood 1991; 78: 1166-1172.
6. Sadowitz PD, Smith SD, Schuster J et al. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood 1993; 81: 602-609.
7. Steinherz PG. CNS leukemia: problem of diagnosis, treatment, and outcome. J Clin Oncol 1995; 13: 310-313.
8. Bleyer WA. Central nervous system leukemia. Pediatr Clin North Am 1988; 35: 789-814.
9. Gelber DR, Sallan SE, Cohen HJ et al. Central nervous system treatment in childhood acute lymphoblastic leukemia. Cancer 1993; 72: 261-270.
10. Tubergen DG, Gilchrist GS, O'Brien RT et al. Prevention of CNS disease in intermediate risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Children Cancer Group Report. J Clin Oncol 1993; 11: 520-526.
11. Ortega JA, Nesbit ME, Sather HN et al. Long-term evaluation of a CNS prophylaxis trial-treatment comparison and outcome after CNS relapse in childhood ALL: a report from the Children's Cancer Study Group. J Clin Oncol 1987; 5: 1646-1654.
12. Bowman WP, Aur RJA, Ustu OH, Rivera G. Isolated testicular relapse in acute lymphocytic leukemia of childhood: categories and influence on survival. J Clin Oncol 1984; 2: 924-929.
13. Uderzo C, Zurlo MG, Adamoli L et al. Treatment of isolated testicular relapse in childhood acute lymphoblastic leukemia: an Italian Multicenter Study. J Clin Oncol 1990; 8: 672-677.
14. Buchanan GR, Boyett JM, Pollock BH et al. Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. Cancer 1991; 68: 48-55.
15. Sanders JE, Thomas ED, Buckner CD, Doney K. Marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 1987; 70: 324-326.
16. Uderzo C, Valsecchi MG, Bacigalupo A et al. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten year experience of the Italian bone marrow transplantation group and Italian paediatric hematology oncology association. J Clin Oncol 1995; 13: 352-358.
17. Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. New Engl J Med 1994; 331: 1253-1258.
18. Balduzzi A, Gooley T, Anasetti C et al. Unrelated donor marrow transplantation in children. Blood 1995; 8: 3247-3256.
19. Rossetti F, Messina C, Miniero R et al. ABMT for early isolated extramedullary relapse of childhood ALL. Bone Marrow Transplant 1993; 12: 37-41.
20. Borgmann A, Hartmann R, Schmid H et al. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. Bone Marrow Transplant 1995; 15: 515-521.
21. Sallan SE, Niemeyer CM, Billet AL et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia. J Clin Oncol 1989; 7: 1594-1601.
22. Billett AL, Kornmehl E, Tarbell NJ et al. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood 1993; 81: 1651-1657.
23. Parsons SK, Castellino SM, Lehmann LE et al. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children. Bone Marrow Transplant 1996; 17: 763-768.
24. Paolucci G, Masera G, Vecchi V et al. Treating childhood acute lymphoblastic leukemia (ALL): summary of ten years' experience in Italy. Med Pediatr Oncol 1987; 17: 83-91.
25. Vecchi V, Aricò M, Basso G et al. Risk-directed therapy for childhood acute lymphoblastic leukemia. Cancer 1993; 72 (Suppl. 8): 2517-2524.
26. Conter V, Aricò M, Valsecchi MG et al. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster-based intensive chemotherapy. J Clin Oncol 1995; 13: 2497-2502.
27. Rossi MR, Masera G, Zurlo MG et al. Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1986; 3: 101-120.
28. Giona F, Testi AM, Annino L et al. Treatment of primary and relapsed acute lymphoblastic leukemia in children and adults: the GIMEMA/AIEOP experience. Br J Haematol 1994; 86: 55-61.
29. Gorin NC, Douay L, Laporte JP et al. Autologous bone marrow transplantation using marrow incubated with Asia Z 7557 in adult leukemia. Blood 1986; 67: 1367-1376.
30. Andolina M, Agosti E, Meraviglia L et al. Bone marrow purging with vincristine and methylprednisolone. J Cell Biochem 1988; 12C (Suppl. 3): 84 (Abstr. 125).
31. Colleselli P, Rossetti F, Messina C et al. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in remission: first choice for isolated extrmedullary relapse. Bone Marrow Transplant 1994; 14: 821-825.
32. Pearson ES, Hartley HO. Biometrika Tables for Statisticians. Cambridge University Press: Cambridge, 1996.
33. Kaplain EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
34. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
35. Cox DR. Regression models and life-tables. JR Statist Soc 1972; 34: 187-220.
36. Kersey JH, Weisdorf D, Nesbit ME et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. New Engl J Med 1987; 317: 461-467.
37. Schroeder H, Pinkerton CR, Powles RL et al. High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse. Bone Marrow Transplant 1991; 7: 11-15.
38. Baumgarten E, Schmid H, Pohl U et al. Low-dose natural interleukin-2 and recombinant interferon-gamma following autologous bone marrow grafts in pediatric patients with high-risk acute leukemia. Leukemia 1994; 8: 850-855.
39. Takaue Y, Watanabe A, Murakami T et al. High-dose chemotherapy and blood stem cell autografts for children with first relapse acute lymphoblastic leukemia: a pilot study of the Children's Cancer and Leukemia Study Group of Japan (CCLSG). Med Pediatr Oncol 1994; 23: 20-25.
40. Borgmann A, Schmid H, Hartmann R et al. Autologous bone marrow transplants compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis. Lancet 1995; 346: 873-876.
41. Badell I, Ortega JJ, Munoz A et al. BMT for early isolated extramedullary relapse of childhood ALL: report of 19 cases. Bone Marrow Transplant 1995; 15 (Suppl. 2): S64 (Abstr. 277).
42. Baruchel A, Auclerc MF, Bordigoni P et al. Allogeneic bone marrow transplantation. Blood 1996; 86 (Suppl. 1): 384a (Abstr. 1525).
43. Messina C, Valsecchi MG, Aricò M et al. Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. Bone Marrow Transplant 1998; 21: 9-14.
44. Ganem G, Kuentz M, Bernaudin F et al. Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission. Cancer 1989; 64: 1796-1804.
45. Winik NJ, Smith SD, Shuster J et al. Treatment of CNS relapse in children with acute lymphoblastic leukemia: Pediatric Oncology Study Group. J Clin Oncol 1993; 11: 271-278.
46. Ribeiro RC, Rivera GK, Hudson M et al. An intensive retreatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia. J Clin Oncol 1995; 13: 333-338.
47. Gilmore MJML, Hamon MD, Prentice HG et al. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukemia in first complete remission. Bone Marrow Transplant 1991; 8: 19-26.
48. Gulati SC, Lemali RM, Acaba L et al. Purging in autologous and allogeneic bone marrow transplantation. Curr Opin Oncol 1992; 4: 264-271.
49. Gribben GJ, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New Engl J Med 1991; 325: 1525-1533.
50. Allavena P, Damia G, Colombo T et al. Lymphokine-activated killer (LAK) and monocyte-mediated cytotoxicity on tumor cell lines resistant to antitumor agents. Cell Immunol 1989; 120: 250-258.
51. Weisdorf DJ, Anderson PM, Blazar BR et al. Interleukin 2 immediately after autologous bone marrow transplantation for acute lymphoblastic leukemia. A Phase I Study. Transplantation 1993; 55: 61-66.
52. Blaise D, Olive D, Stoppa AM et al. Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation. Blood 1990; 76: 1092-1097.
53. Higuchi CM, Thompson JA, Peterson FB et al. Toxicity and immunomodulatory effects of interleukin-2 after autologous bone marrow transplantation for hematologic malignancies Blood 1991; 77: 2561-2568.
54. Yeager A, Vogelsang G, Jones R et al. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia. Blood 1992; 79: 3031-3035.